Background: Variable effects limit the efficacy of transcranial direct current stimulation (tDCS) as a research and therapeutic tool. Conventional application of a fixed-dose of tDCS does not account for inter-individual differences in anatomy (e.g. skull thickness), which varies the amount of current reaching the brain. Individualised dose-control may reduce the variable effects of tDCS by reducing variability in electric field intensities at a cortical target site.
Introduction
Non-invasive electrical stimulation, including transcranial direct current stimulation (tDCS) uses a weak constant or alternating electrical current to influence neural activity in cortical networks [1, 2] . This can modify behaviour [3] [4] [5] in both health and disease [6] [7] [8] [9] . Unlocking the therapeutic potential however, is limited by the variable effects of stimulation, which could contribute to the small effect sizes often reported [10] [11] [12] [13] . This known variability mandates novel approaches that increase the efficacy and reliability of the technique.
One major cause of variable effects and individual differences of tDCS are inter-individual variations in anatomy [14, 15] . Anatomical variation, such as skull and cerebrospinal thickness, sulcal depth, and cortical folding, can influence the spread and intensity of current reaching the brain [16] [17] [18] [19] . For example, skull conductivity strongly affects the amount and direction of current entering the brain [20] [21] [22] .
Indeed, variation in E-field intensity at a cortical target region has been estimated to be around 100% [17] . Under the assumption that the E-field in a brain region directly relates to the physiological and behavioural effect of stimulation, this substantial variation alone could explain a large proportion of variable outcomes across individuals and studies.
Nevertheless, the conventional application of a fixed intensity of tDCS stimulator output (e.g. 1 or 2mA) across individuals ignores how much current actually reaches the brain in a given individual. This "one-size-fits-all" approach results in substantial variation in E-fields in cortex [20, 23] .
Reduction of inter-individual variability may be possible using current flow modelling [24] [25] [26] [27] . This provides estimates of E-field across an individual's brain, given a specific electrode montage and stimulator output. Recent studies using intracranial recordings in animals and human patients demonstrate a close qualitative correspondence between model estimates and measured E-fields [28] [29] [30] [31] [32] . These models may therefore provide the opportunity to quantify how much current is delivered into the brain, and where.
However, few studies have utilised current flow modelling to control the dose of the E-field actually delivered within and across individuals. Most commonly, these models have been used for individualising the electrode montage to target a specific cortical target [24, 30] . For example, Dmochowski and colleagues [28] found a 64% increase in electric current in a cortical target and 38% improvement in a behavioural task using individualised tDCS montages in stroke patients. However, with this method of dose-control the intensity of Efield in the target region is not fixed across individuals.
Individualising electrode montage, such as in stroke patients [28] also substantially increases variability in the spatial distribution of current flow across brain regions and individuals.
Here we made the assumption that the physiological and behavioural effects of tDCS primarily arise from a specifically targeted cortical region.
Here we propose a simple and alternative method of dose-control, where stimulator output is individualised and electrode montage is fixed across individuals. Using current flow models, one can determine the tDCS intensity needed to deliver a target E-field intensity to a given cortical target site in each individual (see Figure 1 for a visualisation of this concept).
Whilst this approach does not eliminate variance in current flow distribution, it may result in more consistent distribution of current than if variable electrode montages were used.
The present study formally quantified and compared E-field intensity and distribution across the brain when delivering (i) a fixed intensity of tDCS to all individuals, and (ii) dose-controlled tDCS delivering the same E-field at a cortical target site across individuals.
Specifically, we applied tDCS over the left primary motor cortex, one of the most common targets of electrical stimulation [1, [33] [34] [35] . These models were conducted using a 'directional' electrode montage, in which the electrodes are placed anteriorly and posteriorly to the primary motor cortex (M1) such that current flow is directed perpendicularly to the central sulcus. This montage has been used to minimize variation in the direction of current flow at the target site [36] [37] [38] . We compared this with the 'conventional' electrode montage used to target M1, in which the anode is placed over M1 and the cathode over the contralateral forehead [1, 39] .
We confirm that delivery of conventional fixed-dose stimulation varies E-field intensity at a cortical target site by more than 100% between two groups. These intensities can vary by a factor of two with relatively small sample sizes (N=15). Moreover, this approach leads to substantial variation in E-field distribution across the brain. Critically, E-fields at intensities thought sufficient for physiological targeting are widespread and consistently encompass the regions between stimulation electrodes.
By contrast, dose-controlled tDCS ensures the same E-field intensity is delivered to a cortical target site, here left M1. However, the spread of current remains widespread. We argue that reducing the variable outcomes of non-invasive electrical stimulation requires individualised dose-control or vastly increased sample sizes [40, 41] .
Figure 1. A fixed-dose of tES results in variable E-field distribution across the brain and
intensity delivered to the cortical target site (e.g. left M1). Individualising-dose results in variable stimulator output for each individual, but constant electrical field intensity at the cortical target site. 
Materials and Methods

Structural MRIs
Current Flow Modelling
We estimated current flow throughout cortex in individual brains using Realistic Volumetric Approach to Simulate Transcranial Electric Stimulation (ROAST) software package, version 2.7 (https://www.parralab.org/roast/) [26] . ROAST is an end-to-end pipeline that automatically processes individual MRI volumes to generate a 3D rendering of E-field distribution based on user-defined tDCS protocol. ROAST accepts a 1mm 3 resolution MRI image, which is segmented using SPM12 (https://www.fil.ion.ucl.ac.uk/spm/) into grey matter, white matter, cerebrospinal fluid (CSF), bone, skin, and air cavities. Automatic touch-up of the segmented images to remove holes is completed using morphological operations and simple heuristics (detailed in [26, 30] ). Electrodes are then placed on the scalp surface based on user-defined 10-10 coordinates. Using iso2mesh [43] , a volumetric mesh is generated from 3D multi-domain images to generate the finite element model. The model is then solved for voltage and E-field distribution using getDP [44] . Conductivity In order to extract E-field intensity and distribution in the brain, structural MRI and E-field images produced by ROAST were pre-processed using SPM12. Structural and E-field images were normalised (resampled to 2x2x2mm voxels) into standard space (Montreal Neurological Institute; MNI template) and then smoothed using a 4mm full-width at halfmaximum Gaussian kernel. Images were smoothed to increase signal to noise ratio and improve accuracy of observed E-fields when conducting group-level analyses. An explicit binary mask of grey and white matter was created using the normalised structural images in order to constrict subsequent analyses to voxels within the brain. First, average grey and white matter tissue masks were created using the non-binary tissue masks produced by ROAST for each individual during segmentation. These masks were then transformed into binary grey and white matter tissue masks, with an inclusion threshold of >0.1 intensity.
Binary grey and white matter masks were then combined to create one mask of the brain.
See Figure 2 for complete pipeline. Finally, an anatomical template was generated to visualise the data by averaging the structural MRI images of all individuals. (1) , each tissue type is segmented (2) , electrodes are applied (3) , and the finite element model (FEM) is solved (4) . Using SPM12, the structural MRI and E-field images are then normalised and smoothed (5) , a grey and white matter explicit mask is created (6) , and applied to the E-field to constrict analyses to within the brain (7) . Step 7 shows the regions of interest: left M1 (purple), right M1 (green), and cortical sites under the electrodes: left angular gyrus underneath CP5 (red) and left premotor cortex underneath FC1 (blue).
tDCS protocol
Current flow models simulated bipolar application of transcranial direct current stimulation (tDCS) using disc electrodes (6mm radius, 2mm height). Electrodes were placed over 10-10 coordinates CP5 (anode) and FC1 (cathode). This 'directional' electrode montage was selected to target the hand region of the left primary motor cortex (M1), by placing electrodes in a posterior-anterior orientation perpendicular to, and either side of M1 [36, 45] .
Fixed-dose: across two models, the amplitude of stimulator output, and hence the modelled dose were fixed at 1mA and 2mA. These intensities are commonly used in tDCS applications and are known to induce acute excitability changes [46, 47] . Average intensities of electric current (V/m) were then extracted from left M1 across the sample, and used to determine the desired target intensities in left M1.
Individualised-dose: the sample averages for 1mA (M=0.185 ± 0.033V/m) and 2mA (M=0.369 ± 0.064V/m) target intensities in left M1 were 0.185V/m and 0.369V/m respectively. We set these values as target intensities in left M1 for the dose-controlled simulations (i.e. to reduce variance in E-field intensity at the cortical target site). For these current flow models we individualised stimulator output (Individualiseddose) such that the targeted intensity occurred in left M1 for each individual:
Where M1TI is the Target Intensity of E-field in left M1 across individuals, M1AI is the Actual Intensity when applying a fixed-dose (1mA/2mA) for each individual, and Fixeddose is the fixed stimulator output that corresponds to the individualised-dose (e.g. target intensity based on the average intensity when 1mA fixed-dose is applied). The calculated individualised-dose was rounded to the nearest 0.025mA to adhere to parameter limitations of the constant current stimulator produced by NeuroConn (DC-Stimulator Plus; NeuroConn, Ilmenau, Germany).
Data Analysis
Statistical analyses on current flow models produced by ROAST were carried out using MATLAB (The MathWorks, Inc., Natick, MA, USA) and SPM12. Alpha level was 0.05 and analyses were corrected for multiple comparisons using family-wise error correction (FWE).
Regions of interest (ROI):
to assess variance in E-field intensity between individuals in target left M1 (MNI: -38, -20, 50), eigenvariates were extracted from regions of interest (5mm radius). MNI coordinates for left M1 were based on previous activation likelihood estimations [48] . Additional ROIs included the cortex underneath electrode sites, the angular gyrus (AnG; MNI: -54, -46, 22), underneath CP5 and premotor cortex underneath FC1 (PMC; MNI: -24, 4, 66), and right M1 (MNI: 30, -18, 48; [48] ). ROIs for CP5 and FC1 were converted from Talairach coordinates taken from anatomical locations of 10-10 projections [49] , and then extended deeper within the cortex to avoid inclusion of CSF. MNI coordinates specify the centre of each ROI (see Figure 2 for ROIs).
Reproducibility of left M1 intensities with typical sample-sizes:
based on the average Efield intensity observed in left M1 when 1mA fixed-dose was applied, the likelihood of smaller samples yielding similar intensities was investigated. 1000 bootstrap samples of 15 and 30 individuals (i.e. 45,000 resamples in total) were analysed, reflecting sample sizes typically observed in tDCS studies [40, 50] . Each iteration of resampling randomly drew individuals from the original sample (N=50) with replacement. For each bootstrap sample, the average intensity in left M1 was obtained.
Spatial distribution of E-field: one-sample t-tests of E-field images were conducted to identify brain regions where the E-field was significantly above zero. The distribution is described qualitatively, as manipulating the variance in individualised-but not fixed-dose models meant the data was no longer statistically comparable. Topography was explored for the whole sample and two example individuals.
Probability maps of E-field intensities above 0.14V/m: to determine the distribution of Efield intensities above 0.14V/m throughout the brain in a large population, we generated probability maps for 1mA fixed-dose and the corresponding individualised-dose (0.185V/m target intensity in M1). For the individualised-dose models, the E-field images for each subject were summed, and the lowest E-field intensity within the left M1 ROI of the summed image was selected (0.14V/m). For both the fixed-and individualised-dose models, we then created binary images from each individual's normalized E-field images, which included voxels >0.14V/m. We then created probability maps of E-field values exceeding 0.14V/m, by summing these binary images. The summed values were converted into percentage to create the final probability maps.
Comparing E-fields for directional and conventional electrode montages: E-field intensities within ROIs and the spatial distribution of E-fields were measured for the 'conventional' electrode montage [1, 39] . 
Results
Dose-controlled tDCS reduces variance in E-field intensity in left M1
For the directional electrode montage (CP5-FC1) and fixed stimulator output, E-field intensities were highly variable across individuals. Intensities ranged from 0.125-0.249V/m with 1mA (M=0.185V/m ± 0.033), and 0.263-0.518V/m with 2mA (M=0.369V/m ± 0.064). Efield intensities in left M1 therefore varied by ~100% with a given stimulator output.
Interestingly, the most consistent intensities in each model were observed in the right hemisphere (i.e., contralateral to stimulation). The global maximum (i.e. the statistical maximum with least variance in E-field) for 1mA was in the right medial temporal lobe (MNI: Taking this into account, these results suggest that variance in E-field intensities at the target location was essentially eliminated. See Figure 3 for intensities in left M1 and Table 1 for descriptive statistics. Figure 4 ). Therefore, when applying tDCS with a fixed output intensity, the mean intensity of current delivered to a cortical target site can substantially vary across different samples, and this variation in turn is exacerbated for small sample sizes. 
Dose-control does not reduce variance in E-field intensity in non-target regions
Having explored variance in E-field intensity in the target site left M1, the variation in Efields across the brain was assessed. We focussed on the left AnG (underneath CP5), PMC (underneath FC1), and right M1. as done here, removes E-field variance in the target region, it does not therefore greatly alter E-field variance underneath the stimulation electrodes or elsewhere ( Figure 5 , Table 1 ). E-field distribution in individuals exhibiting high (e.g., subject 14) or low (e.g., subject 41)
Regions under stimulation electrodes (left AnG and left PMC):
Right
intensities in left M1 after 1mA fixed-dose illustrate the heterogeneous distribution of Efields across individuals. The E-field in subject 14 extended medially, including much of the left hemisphere's grey and white matter, and left temporal regions, whereas the E-field in subject 41 was less diffuse, with intensities >0.1V/m largely contained in left parietal grey matter (see Figure 6 ).
However, with dose-control, the E-field distribution was comparable in these subjects, matching the distribution observed across the whole sample. This illustrates that E-field distribution becomes more consistent when individualising dose.
Our probability maps corroborate this observation. By combining binary masks of E-field >0.14V/m for each individual, these maps determined the likelihood at each voxel that Efields would exceed this threshold across a large sample. Figure 7 shows that for both fixed- The least statistical variance in E-field was also in left M1 after dose-control (MNI: -38, -20, t(1,49)=161.78, p<.001) . For controlling dose in M1, stimulator output intensities ranged from 0.675-1.700mA (M=1.041mA ± 0.220). This demonstrates that for controlling the Efield delivered to a cortical target site, a fixed stimulator output is not a viable approach (Figure 8 ). 
Regions under stimulation electrodes (left PCG and right aPFC):
in line with the directional montage, fixed-dose tDCS produced highly variable E-fields in left PCG and right aPFC. Range and intensity of E-field in these regions was maintained when applying an individualiseddose to obtain 0.182V/m target intensity in left M1 (see Table 1 ).
Right M1: in contralateral M1, E-field intensities were lower, but importantly still greater than those observed in models using the directional montage when applying either a fixedor an individualised-dose. Notably, there is overlap between the highest intensities observed in contralateral (right) M1 and the lowest intensities observed in left M1. To the extent that one assumes stimulation affects the targeted M1 region, this suggests that in a subgroup of individuals, stimulation can also influence M1 contralateral to the targeted hemisphere (see Figure X) .
Conventional (C3-FP2) electrode montage leads to greater spatial distribution of E-field in the brain Figure 9 shows that E-field intensities exceeding 0.1V/m encompass much of the targeted (left) hemisphere when applying 1mA fixed-dose using a conventional M1 electrode montage. By contrast, for the directional montage, these intensities are largely restricted to the left hemisphere, suggesting that even though intensities in the targeted M1 region are comparable, there are considerable differences in the spatial extent of E-fields across the brain, including subcortical structures. E-field distribution in the brain is widespread, extending contralaterally with higher stimulation doses or when applying lower doses using the conventional electrode montage.
Heterogeneous distribution across individuals with fixed-dose tDCS can be greatly reduced when individualising-dose.
Discussion
A central concern for widespread application of tDCS in health and disease is the known variability of physiological and behavioural outcomes, both between individuals and research studies [10] [11] [12] [13] . Given the assumption that current entering the brain relates directly to the effect of stimulation, variance in E-field will be a major source of variability in tDCS effects. Here, we quantified that inter-individual differences in anatomy can lead to variation in E-field by as much as 100%. However, this variance can be controlled by individualising the dose of tDCS to deliver a fixed cortical E-field.
Dose-control reduces variance in E-field intensities at a cortical target site
When applying a fixed-dose of tDCS, E-field intensities are heterogeneous both across different regions of the brain within an individual, and also across individual subjects. At the cortical target site (left M1), intensities varied by over 100%, which is consistent with previous estimates of E-field variability [17] . Typical application of a fixed-dose of tDCS is therefore likely to lead to variable physiological or behavioural effects across individuals [16] [17] [18] [19] [20] 51] .
With smaller sample sizes (~15-30 individuals) commonly used in basic and translational tDCS studies [40, 50, 53] , this heterogeneity can result in cohorts with entirely different stimulation profiles. Bootstrapped samples illustrated that, on average, for smaller samples the overall intensities in left M1 can vary substantially from our larger population mean.
Therefore, it is not unreasonable to assume that the effectively applied current across studies may vary by a factor of two or more.
Assuming a linear relationship between current delivered to a cortical target and its physiological and behavioural consequences, this variation likely contributes to variable outcomes and hinders reproducibility across studies. Strikingly however, despite much work on modelling current flow induced by electrical stimulation, formal quantification of E-field variance is rarely reported (notable exceptions being [17, 22, 54] ). Controlling for this source of variability must therefore be a priority.
Here we developed a simple and accessible pipeline using current flow modelling [26] and group-level statistics to quantify E-field in the brain when dose-controlling tDCS. Based on intensities in a cortical target (left M1) observed in our cohort, tDCS dose was individualised to produce a fixed cortical E-field in this region across all individuals. In other words, rather than applying the usual fixed stimulator output, this output is adjusted for each individual to deliver the desired target intensity at a cortical target site. Consequently, stimulator output varied by 100% across individuals, but stayed within the safe range (≤4mA) for tDCS applications in a healthy population [46] .
Notably, dose-control did not reduce variance or spread of E-field in other regions. This is entirely expected given the linear properties of Ohm's law. Treating head tissues as pure resistors means that, for example, maintaining electrode montage while simulating a twofold increase in injected current will result in an identical distribution of E-field across the brain, but with a twofold increase in intensity at each cortical location. Specifically, in 
Dose-control reduces variance in spatial distribution of E-field across the whole brain
As expected, our results confirmed that both fixed-and individualised-dose produce comparable E-field distributions across the brain, given a fixed electrode montage. With lower doses (~1mA), intensities over 0.1V/m encompassed large proportions of the left hemisphere, whereas higher doses (~2mA) also included contralateral regions. However, using dose-control these distributions become qualitatively more comparable.
These observations corroborate previous reports that tDCS produces diffuse E-field in the brain [18, 24, 27, 57] . Validation studies reported peak intensities of 0.5V/m [32] and 0.4V/m [31] with 1mA transcranial electrical stimulation, and 0.8V/m when applying 2mA tDCS [31] .
These intensities correspond to those observed at the cortical surface in the present study.
We note that irrespective of whether these values are quantitatively accurate, our results remain qualitatively valid: fixed-dose tDCS results in large E-field variance at a cortical target site and across the brain, which is removed by individualising dose.
In the present study, we applied dose-control with the assumption that physiological or behavioural effects of tDCS relate to E-field intensities delivered to a cortical target in a straightforward (linear) way. In other words, the E-field in a brain region of interest directly determines the likelihood of physiological and behavioural consequences, whether this is an increase or decrease in excitability. We therefore here controlled E-field delivered to this target region.
However, other parameters such as current flow direction, spatial extent, or gradient of polarisation across the cortical surface [58] may be relevant. For example, other brain regions receiving intensities above a certain threshold will likely contribute to the effect of stimulation. In particular, probability maps demonstrate that across the sample, a wide range of cortical regions between electrode sites consistently reach E-field intensities thought to be sufficient for physiological targeting. Future work will address how these parameters could be controlled for.
Individualised application of tDCS likely also requires consideration of differences in structural or functional state of the brain, particularly in ageing [59, 60] or clinical populations such as stroke [25, 61, 62] . We would argue that such development should precede optimization of protocols based on the number of stimulation sessions [63] ), intensity [56, 64] , or individual differences including baseline physiological [65, 66] or cognitive function, such as performance ability [67] or attention [68] .
Our approach uses a straightforward calculation of the required stimulator output given a desired target intensity in a cortical target site. This is distinct from other optimisation approaches determining optimum electrode placement for maximal intensity in a cortical target [18, 29, 69] . Yet, as the effects of tDCS likely arise from interaction of larger networks given the non-focal distribution of current, these may vary substantially for different electrode montages. Further, while numerical optimisation has been proposed to achieve this [70] , it is not commonly available. Moreover, we establish a pipeline for potentially calculating normative datasets for E-field distribution throughout the brain, given a specific electrode montage. In principle this can be achieved with any number of individual brains in a straightforward way, which is relevant given the cost and difficulty obtaining individual brain scans required for current flow modelling. Normative distributions in large cohorts also enable required sample sizes to be formally derived.
Going forward, the utility of current flow modelling requires further investigation, namely to determine whether these models can indeed be used to reduce the physiological or behavioural variability associated with conventional tDCS delivery. As previously noted [20] , there is a surprising lack of such validation in the field, which will inevitably determine the efficacy of current flow modelling. Given that intensity of stimulation influences the degree of membrane polarisation [13, 51, 55] , our prediction is that controlling the delivery of current to the brain will reduce variance in the effects of tDCS.
Recent studies suggest that current flow in a cortical target can predict response to transcranial electrical stimulation [71, 72] . For example, Laakso and colleagues [71] proposed that variability in motor evoked potentials could be partly explained by E-fields in M1 induced by tDCS. Specifically, these authors pointed at the putative relationship between the normal component of E-field in the hand area of M1. As ROAST uses volume rather than surface based segmentation to produce current flow models, it may be beneficial in future work to compare the explanatory power of both volumetric and boundary element methods when determining the effects of tDCS.
Application of our dose-control approach to other electrode montages, such as high definition (HD)-tDCS [29, 73] , or other target sites, will in the future provide a framework for validation of other ways to optimise current delivery.
Conclusion
The present study demonstrates the substantial variability in E-field reaching the brain due to inter-individual differences in anatomy. It also provides a straightforward approach to reduce variance by dose-controlling tDCS using current flow modelling.
This effectively shifts variance from E-field in the cortex to stimulator output. If dose-control also reduces variance in stimulation effects, the efficacy of non-invasive electrical stimulation, including tDCS could be increased.
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